Elective Caesarean Section SurgeriesPhase 3NCT01858090
Intrathecal Levobupivacaine With Opioids for Caesarean Section
A Phase 3 study testing Group Fentanyl, Group sufentanil and Ephedrine in people with Elective Caesarean Section Surgeries, run by Baskent University at 1 site in Turkey (Türkiye).
Trial summary
In this prospective, randomized, double-blind, controlled study, the aim was to compare the effect of adding fentanyl (10 µg) or sufentanil (2.5 µg) to levobupivacaine (2.2±0.2 ml 0.5%) on the intraoperative anesthesia quality, block characteristics, the side effects on the newborn and mother, the duration of… Read more about this study
- Who is it for?
- Ages 19 to 40 years, women only
- Conditions the study is for
- Elective Caesarean Section Surgeries
- What is being tested?
- Group Fentanyl, Group sufentanil and Ephedrine
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 93 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- Jan 2009to Jan 2010
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 40 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Pregnant women
- above 18 years of age
- gestational pregnancy age ≥ 36 weeks
- height ≥ 155 cm
- weight ≤110 kg
- fetal weight ≥ 2500 g)
- American Society of Anesthesiologists (ASA) Physical Status of I to II
- elective caesarean section surgeries were enrolled.
Who cannot join
- Local anesthetic allergy
- history of hypersensitivity and anaphylactic reactions
- emergency surgery
- preeclampsia
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Baskent University School of Medicine Adana Teaching and Research Hospital
Adana, 01250
About this study
Official title: Comparison of Intrathecal Levobupivacaine Combined With Sufentanil, Fentanyl, or Placebo for Elective Caesarean Section: A Prospective, Randomized, Double-blind, Controlled Study
In this prospective, randomized, double-blind, controlled study, the aim was to compare the effect of adding fentanyl (10 µg) or sufentanil (2.5 µg) to levobupivacaine (2.2±0.2 ml 0.5%) on the intraoperative anesthesia quality, block characteristics, the side effects on the newborn and mother, the duration of postoperative analgesia, and surgeon satisfaction score.
Read the detailed description
Following the approval of the Baskent University Ethics Committee (KA08/48) and the written informed consents of the patients, 93 pregnant women above 18 years of age without fetal distress/anomaly (gestational pregnancy age ≥ 36 weeks, height ≥ 155 cm, weight ≤110 kg, and fetal weight ≥ 2500 g) and planned American Society of Anesthesiologists (ASA) Physical Status of I to II elective caesarean section surgeries were enrolled. Patients with allergies to any local anesthetic, with a history of hypersensitivity and anaphylactic reactions, who were taken to emergency surgery, and who had preeclampsia were excluded.
Patients were randomized into three groups (Fentanyl Group F, Sufentanil Group S, Control Group C) by a computer, and the demographic data and gestational age of the patients were recorded. No premedications were administered. Following monitoring in all patients (with non-invasive blood pressure, electrocardiogram and pulse oxymeter), Ringer's Lactate solution (15 ml/kg) was administered for 10-15 minutes. Spinal anesthesia was administered with midline approach at the L3-4 interval while the patients assumed a seated position. Spinal blocks were performed by an anesthesiologist blinded to the drug injected, and the drug syringes were prepared immediately before injection by another anesthesiologist who otherwise was not involved in the study. Intraoperative and postoperative assessments were performed by an anesthesiologist blinded to patient allocations and study drugs. 2.2 ml (11 mg) levobupivacaine (Chirocaine®, Abbott Laboratories, Ireland) was administered to patients with heights <163 cm, while 2.4 ml (12 mg) levobupivacaine was administered to patients with heights ≥163 cm (Control Group). 2.2±0.2 ml 0.5% levobupivacaine + 10 µg fentanil (Fentanyl®, Johnson\&Johnson, USA) was administered to Group F and 2.2±0.2 ml levobupivacaine + 2.5 µg sufentanil (Sufenta®, Johnson\&Johnson, USA) was administered to Group S at rate of 3ml/30 sec. Following intrathecal administration, patients were placed in the supine position, and their heads were slightly elevated. Patients were then brought to a 15-20° left lateral position to prevent aortocaval compression, and oxygen (at 2-4 L/min) was provided with a face mask.
Sensory block was evaluated every two minutes with a pin prick test, while motor block was evaluated with the Bromage scale (0=no motor loss; 1= inability to flex the hip; 2= inability to flex the knee; 3= inability to flex the ankle). Onset times for sensory and motor blocks were recorded. Surgical intervention was initiated when block reached the T5 level. In case sensory block did not attain the T5 level within 20 minutes, general anesthesia was administered.
Duration of sensory block, highest level of sensory block, time to L1-T10 level, time for two-segment and T10 sensory block regression, and the onset and end time of motor block were recorded.
Systolic and diastolic blood pressures (SBP and DBP), heart rate (HR) and oxygen saturations (SpO2) were evaluated every three minutes during the first 15 minutes, and every five minutes afterwards. If systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to <100 mmHg, fluid loading and ephedrine (5 mg) were administered. A decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered. A decrease in the respiratory rate to less than 10/min, and a decrease in oxygen saturation to less than 90%, was considered as indications of respiratory depression. In such cases, support was provided with face mask ventilation.
APGAR scores were evaluated (at minutes 1 and 5) by a pediatrician with no information regarding the groups. For blood gas measurements, samples were obtained from the umbilical cord of newborns.
Intraoperative pain evaluation was performed with the visual analog scale (VAS score; 0= No pain, 10= worst pain possible) while performing surgical incision, uterine incision, and skin closure. In cases where VAS>3, IV fentanyl (50 µg) was administered. Sedation levels were monitored, and propofol (up to 0.5 mg/kg) was administered if patients had discomfort. When patients required more than 50 µg fentanyl and/or 0.5 mg/kg propofol, the block was considered as unsuccessful and general anesthesia was administered. Intraoperative and postoperative nausea, vomiting, pruritus, respiratory depression and other side effects were recorded at the first, second, sixth, and twelfth hours. Metoclopramide (10 mg IV) was administered for nausea, and diphenhydramine (25 mg) was administered for severe pruritus, Surgery procedures were performed by the same surgeon with no knowledge regarding the groups. Surgeon satisfaction score was evaluated according to the sufficiency of muscle relaxation and the provision of adequate surgical conditions (0= pair, 1= fair, 2= good, 3= excellent).
The time of first analgesic requirement was recorded for the patients, and pethidine hydrochloride (50 mg IM) was administered as the first analgesic. Following this, analgesic treatment was continued with diclofenac sodium (75 mg IM) as additional analgesic among cases in which VAS>3. Diclofenac sodium requirement during the first 24 hours were recorded.
Statistical Analysis Sensory block duration was used as main end-point for statistical analysis. Power analysis based on previous studies14,15 indicated that the minimum number of patients required for 80% power (α=0,05, β=0,20) was 24 per group for detecting 25% difference in sensory block duration. Statistical analysis was performed using SPSS version 17.0 (SPSS Inc, Chicago, Illinois). Categorical measurements were recorded as numbers and percentages, continuous measurements with mean and standard deviation (Mean±SD), and also with the median (minimum-maximum) where necessary. In the comparison of categorical variables, the chi-square test or the Fischer's exact test were used. The ANOVA test was used for distributions, in the comparison of continuous measurements between the groups, while the Kruskal-Wallis test was used for parameters without normal distribution. Hemodynamic data were analyzed with repeated measure analyses. Values of p<0.05 were considered statistically significant.
- Conditions
- Elective Caesarean Section Surgeries
- Being tested
- Control Group Chirocaine, Group Fentanyl, Group sufentanil, Ephedrine, Atropine sulfate
- Keywords
- spinal anesthesia, caesarean section, local anesthetics, levobupivacaine, sufentanil, fentanyl, above 18 years of age, pregnant women, multiparous, nulliparous
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Control Group ChirocaineDrug
Also called Chirocaine, Chirocaine®, Abbott Laboratories, Ireland, 113/13, 16.12.2002
Control group: Spinal anesthesia with levobupivacaine+Serum Physiologic %0.9 (Total volume 3 mL)
Group FentanylDrug
Also called Fentanyl®, Johnson&Johnson, USA, 110/53, 01.08.2001
Group sufentanilDrug
Also called Sufenta®, Johnson&Johnson, USA, 108/26, 15.08.2000
EphedrineDrug
Also called EFEDRİN HİDROKLORÜR AMPUL 0.05 g, 1 ml, 30.06.1999 - 192/42, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBUL
If systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to <100 mmHg, fluid loading and ephedrine (5 mg) were administered.
Atropine sulfateDrug
Also called ATROPİN SÜLFAT AMPUL 1/4 mg, 1 ml, 30.06.1999 - 192/9, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBUL
A decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered
PropofolDrug
Also called Propofol Ampul, Abbott Laboratories, USA, 23.12.1998 - 105/37
Intravenous propofol (up to 0.5 mg/kg) was administered if patients had discomfort
MetoclopramideDrug
Also called Metpamid Ampul, Üretici Firma:YENI ILAC VE HAMMADDELERI SANAYI VE TICARET A.S., Esenyurt/ISTANBUL, 300188-1 BR
Metoclopramide (10 mg IV) was administered for nausea
DiphenhydramineDrug
Also called Benison Ampul, Osel İlaç, 8699788750300
for severe pruritus
pethidine hydrochlorideDrug
Also called Aldolan ampul, Liba Laboratuarları A.Ş., 20.12.1985 - 86/29, Gerot Pharmazeutika GmbH, Arnethgasse 3, 1171 Viyana, Avusturya
pethidine hydrochloride (50 mg IM) was administered as the first analgesic postoperatively
Diclofenac sodiumDrug
Also called Diclomec Ampul 75 mg/ 3 ml, Mecom Saglik Urunleri San. ve Tic. A.S, 8699633759366
as additional analgesic among cases in which VAS>3(Postoperatively)
| Study group | Role | What they receive |
|---|---|---|
| Control Group | Placebo comparator | Control Group, Group C: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ Serum saline Receives: Drug: Control Group Chirocaine; Drug: Ephedrine; Drug: Atropine sulfate; Drug: Propofol; Drug: Metoclopramide; Drug: Diphenhydramine; Drug: pethidine hydrochloride; Drug: Diclofenac sodium |
| Group Fentanyl | Active comparator | Group Fentanyl, Group F: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml+fentanyl (10 µg) Receives: Drug: Group Fentanyl; Drug: Ephedrine; Drug: Atropine sulfate; Drug: Propofol; Drug: Metoclopramide; Drug: Diphenhydramine; Drug: pethidine hydrochloride; Drug: Diclofenac sodium |
| Group sufentanil | Active comparator | Group sufentanil, Group S: spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ sufentanil (2.5 µg) Receives: Drug: Group sufentanil; Drug: Ephedrine; Drug: Atropine sulfate; Drug: Propofol; Drug: Metoclopramide; Drug: Diphenhydramine; Drug: pethidine hydrochloride; Drug: Diclofenac sodium |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparison of the effect of adding fentanyl or sufentanil to levobupivacaine (2.2±0.2 ml 0.5%) on intraoperative anesthesia quality block characteristics side effects on newborn and mother,duration of postoperative analgesia,surgeon satisfaction score
Measured: during caesarean section and postoperative first 24 hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 May 2013 (estimated)
- Study startJan 2009
- Primary completionOct 2009
- Study completionJan 2010
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Elective Caesarean Section SurgeriesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 93 participants (actual)
Sponsor and investigators
- Lead sponsor
- Baskent University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nesrin Bozdogan Ozyilkan, Baskent University
- Investigators
- Anis Aribogan, Prof., MD, Study director, Baskent University School of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01858090
- Sponsor's protocol ID
- KA08/48
- Status last verified
- May 2013
- First submitted
- 2 May 2013
- Last updated
- 21 May 2013
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Karaman S, Kocabas S, Uyar M, Hayzaran S, Firat V. The effects of sufentanil or morphine added to hyperbaric bupivacaine in spinal anaesthesia for caesarean section. Eur J Anaesthesiol. 2006 Apr;23(4):285-91. doi: 10.1017/S0265021505001869. Epub 2006 Jan 27.
PubMed 16438758Bozdogan Ozyilkan N, Kocum A, Sener M, Caliskan E, Tarim E, Ergenoglu P, Aribogan A. Comparison of intrathecal levobupivacaine combined with sufentanil, fentanyl, or placebo for elective caesarean section: a prospective, randomized, double-blind, controlled study. Curr Ther Res Clin Exp. 2013 Dec;75:64-70. doi: 10.1016/j.curtheres.2013.09.003.
PubMed 24465046
Study at a glance
From the registry record, last updated by the sponsor on 21 May 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Intrathecal Levobupivacaine Combined With Sufentanil, Fentanyl, or Placebo for Elective Caesarean Section: A Prospective, Randomized, Double-blind, Controlled Study
- ClinicalTrials.gov ID
- NCT01858090
- Acronym / sponsor ID
- KA08/48
- Conditions
- Elective Caesarean Section Surgeries
- Keywords
- spinal anesthesia, caesarean section, local anesthetics, levobupivacaine, sufentanil, fentanyl, above 18 years of age, pregnant women
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 93 participants (actual)
- Lead sponsor
- Baskent UniversityUniversity, hospital or other
- Study start
- Jan 2009
- Primary completion
- Oct 2009 (actual)
- Study completion
- Jan 2010 (actual)
- First posted
- 21 May 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this prospective, randomized, double-blind, controlled study, the aim was to compare the effect of adding fentanyl (10 µg) or sufentanil (2.5 µg) to levobupivacaine (2.2±0.2 ml 0.5%) on the intraoperative anesthesia quality, block characteristics, the side effects on the newborn and mother, the duration of postoperative analgesia, and surgeon satisfaction score.
Detailed description
Following the approval of the Baskent University Ethics Committee (KA08/48) and the written informed consents of the patients, 93 pregnant women above 18 years of age without fetal distress/anomaly (gestational pregnancy age ≥ 36 weeks, height ≥ 155 cm, weight ≤110 kg, and fetal weight ≥ 2500 g) and planned American Society of Anesthesiologists (ASA) Physical Status of I to II elective caesarean section surgeries were enrolled. Patients with allergies to any local anesthetic, with a history of hypersensitivity and anaphylactic reactions, who were taken to emergency surgery, and who had preeclampsia were excluded.
Patients were randomized into three groups (Fentanyl Group F, Sufentanil Group S, Control Group C) by a computer, and the demographic data and gestational age of the patients were recorded. No premedications were administered. Following monitoring in all patients (with non-invasive blood pressure, electrocardiogram and pulse oxymeter), Ringer's Lactate solution (15 ml/kg) was administered for 10-15 minutes. Spinal anesthesia was administered with midline approach at the L3-4 interval while the patients assumed a seated position. Spinal blocks were performed by an anesthesiologist blinded to the drug injected, and the drug syringes were prepared immediately before injection by another anesthesiologist who otherwise was not involved in the study. Intraoperative and postoperative assessments were performed by an anesthesiologist blinded to patient allocations and study drugs. 2.2 ml (11 mg) levobupivacaine (Chirocaine®, Abbott Laboratories, Ireland) was administered to patients with heights <163 cm, while 2.4 ml (12 mg) levobupivacaine was administered to patients with heights ≥163 cm (Control Group). 2.2±0.2 ml 0.5% levobupivacaine + 10 µg fentanil (Fentanyl®, Johnson\&Johnson, USA) was administered to Group F and 2.2±0.2 ml levobupivacaine + 2.5 µg sufentanil (Sufenta®, Johnson\&Johnson, USA) was administered to Group S at rate of 3ml/30 sec. Following intrathecal administration, patients were placed in the supine position, and their heads were slightly elevated. Patients were then brought to a 15-20° left lateral position to prevent aortocaval compression, and oxygen (at 2-4 L/min) was provided with a face mask.
Sensory block was evaluated every two minutes with a pin prick test, while motor block was evaluated with the Bromage scale (0=no motor loss; 1= inability to flex the hip; 2= inability to flex the knee; 3= inability to flex the ankle). Onset times for sensory and motor blocks were recorded. Surgical intervention was initiated when block reached the T5 level. In case sensory block did not attain the T5 level within 20 minutes, general anesthesia was administered.
Duration of sensory block, highest level of sensory block, time to L1-T10 level, time for two-segment and T10 sensory block regression, and the onset and end time of motor block were recorded.
Systolic and diastolic blood pressures (SBP and DBP), heart rate (HR) and oxygen saturations (SpO2) were evaluated every three minutes during the first 15 minutes, and every five minutes afterwards. If systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to <100 mmHg, fluid loading and ephedrine (5 mg) were administered. A decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered. A decrease in the respiratory rate to less than 10/min, and a decrease in oxygen saturation to less than 90%, was considered as indications of respiratory depression. In such cases, support was provided with face mask ventilation.
APGAR scores were evaluated (at minutes 1 and 5) by a pediatrician with no information regarding the groups. For blood gas measurements, samples were obtained from the umbilical cord of newborns.
Intraoperative pain evaluation was performed with the visual analog scale (VAS score; 0= No pain, 10= worst pain possible) while performing surgical incision, uterine incision, and skin closure. In cases where VAS>3, IV fentanyl (50 µg) was administered. Sedation levels were monitored, and propofol (up to 0.5 mg/kg) was administered if patients had discomfort. When patients required more than 50 µg fentanyl and/or 0.5 mg/kg propofol, the block was considered as unsuccessful and general anesthesia was administered. Intraoperative and postoperative nausea, vomiting, pruritus, respiratory depression and other side effects were recorded at the first, second, sixth, and twelfth hours. Metoclopramide (10 mg IV) was administered for nausea, and diphenhydramine (25 mg) was administered for severe pruritus, Surgery procedures were performed by the same surgeon with no knowledge regarding the groups. Surgeon satisfaction score was evaluated according to the sufficiency of muscle relaxation and the provision of adequate surgical conditions (0= pair, 1= fair, 2= good, 3= excellent).
The time of first analgesic requirement was recorded for the patients, and pethidine hydrochloride (50 mg IM) was administered as the first analgesic. Following this, analgesic treatment was continued with diclofenac sodium (75 mg IM) as additional analgesic among cases in which VAS>3. Diclofenac sodium requirement during the first 24 hours were recorded.
Statistical Analysis Sensory block duration was used as main end-point for statistical analysis. Power analysis based on previous studies14,15 indicated that the minimum number of patients required for 80% power (α=0,05, β=0,20) was 24 per group for detecting 25% difference in sensory block duration. Statistical analysis was performed using SPSS version 17.0 (SPSS Inc, Chicago, Illinois). Categorical measurements were recorded as numbers and percentages, continuous measurements with mean and standard deviation (Mean±SD), and also with the median (minimum-maximum) where necessary. In the comparison of categorical variables, the chi-square test or the Fischer's exact test were used. The ANOVA test was used for distributions, in the comparison of continuous measurements between the groups, while the Kruskal-Wallis test was used for parameters without normal distribution. Hemodynamic data were analyzed with repeated measure analyses. Values of p<0.05 were considered statistically significant.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Control Group | Placebo comparator | Drug: Control Group Chirocaine, Drug: Ephedrine, Drug: Atropine sulfate, Drug: Propofol, Drug: Metoclopramide, Drug: Diphenhydramine, Drug: pethidine hydrochloride, Drug: Diclofenac sodiumControl Group, Group C: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ Serum saline |
| Group Fentanyl | Active comparator | Drug: Group Fentanyl, Drug: Ephedrine, Drug: Atropine sulfate, Drug: Propofol, Drug: Metoclopramide, Drug: Diphenhydramine, Drug: pethidine hydrochloride, Drug: Diclofenac sodiumGroup Fentanyl, Group F: Spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml+fentanyl (10 µg) |
| Group sufentanil | Active comparator | Drug: Group sufentanil, Drug: Ephedrine, Drug: Atropine sulfate, Drug: Propofol, Drug: Metoclopramide, Drug: Diphenhydramine, Drug: pethidine hydrochloride, Drug: Diclofenac sodiumGroup sufentanil, Group S: spinal anesthesia with levobupivacaine %0.5 (2.2±0.2 ml)+ sufentanil (2.5 µg) |
Who may qualify
- Ages
- 19 to 40 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Pregnant women
- above 18 years of age
- gestational pregnancy age ≥ 36 weeks
- height ≥ 155 cm
- weight ≤110 kg
Key exclusion criteria (4 listed)
- Local anesthetic allergy
- history of hypersensitivity and anaphylactic reactions
- emergency surgery
- preeclampsia
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Control Group ChirocaineAlso: Chirocaine, Chirocaine®, Abbott Laboratories, Ireland, 113/13, 16.12.2002Control group: Spinal anesthesia with levobupivacaine+Serum Physiologic %0.9 (Total volume 3 mL) | Drug | Control Group |
| Group FentanylAlso: Fentanyl®, Johnson&Johnson, USA, 110/53, 01.08.2001 | Drug | Group Fentanyl |
| Group sufentanilAlso: Sufenta®, Johnson&Johnson, USA, 108/26, 15.08.2000 | Drug | Group sufentanil |
| EphedrineAlso: EFEDRİN HİDROKLORÜR AMPUL 0.05 g, 1 ml, 30.06.1999 - 192/42, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBULIf systolic blood pressure values decreased more than 20% with respect to the baseline values, or decreased to <100 mmHg, fluid loading and ephedrine (5 mg) were administered. | Drug | Control Group, Group Fentanyl, Group sufentanil |
| Atropine sulfateAlso: ATROPİN SÜLFAT AMPUL 1/4 mg, 1 ml, 30.06.1999 - 192/9, OSEL İlaç San. ve Tic. A.Ş. Beykoz/İSTANBULA decrease in heart rate to less than 55 beats/min was considered as bradycardia, and atropine (0.5 mg) was administered | Drug | Control Group, Group Fentanyl, Group sufentanil |
| PropofolAlso: Propofol Ampul, Abbott Laboratories, USA, 23.12.1998 - 105/37Intravenous propofol (up to 0.5 mg/kg) was administered if patients had discomfort | Drug | Control Group, Group Fentanyl, Group sufentanil |
| MetoclopramideAlso: Metpamid Ampul, Üretici Firma:YENI ILAC VE HAMMADDELERI SANAYI VE TICARET A.S., Esenyurt/ISTANBUL, 300188-1 BRMetoclopramide (10 mg IV) was administered for nausea | Drug | Control Group, Group Fentanyl, Group sufentanil |
| DiphenhydramineAlso: Benison Ampul, Osel İlaç, 8699788750300for severe pruritus | Drug | Control Group, Group Fentanyl, Group sufentanil |
| pethidine hydrochlorideAlso: Aldolan ampul, Liba Laboratuarları A.Ş., 20.12.1985 - 86/29, Gerot Pharmazeutika GmbH, Arnethgasse 3, 1171 Viyana, Avusturyapethidine hydrochloride (50 mg IM) was administered as the first analgesic postoperatively | Drug | Control Group, Group Fentanyl, Group sufentanil |
| Diclofenac sodiumAlso: Diclomec Ampul 75 mg/ 3 ml, Mecom Saglik Urunleri San. ve Tic. A.S, 8699633759366as additional analgesic among cases in which VAS>3(Postoperatively) | Drug | Control Group, Group Fentanyl, Group sufentanil |
Primary outcome
Comparison of the effect of adding fentanyl or sufentanil to levobupivacaine (2.2±0.2 ml 0.5%) on intraoperative anesthesia quality block characteristics side effects on newborn and mother,duration of postoperative analgesia,surgeon satisfaction score
Time frame: during caesarean section and postoperative first 24 hours
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 May 2013.
- Background: PubMed 16438758Karaman S, Kocabas S, Uyar M, Hayzaran S, Firat V. The effects of sufentanil or morphine added to hyperbaric bupivacaine in spinal anaesthesia for caesarean section. Eur J Anaesthesiol. 2006 Apr;23(4):285-91. doi: 10.1017/S0265021505001869. Epub 2006 Jan 27.
- Derived from this study: PubMed 24465046Bozdogan Ozyilkan N, Kocum A, Sener M, Caliskan E, Tarim E, Ergenoglu P, Aribogan A. Comparison of intrathecal levobupivacaine combined with sufentanil, fentanyl, or placebo for elective caesarean section: a prospective, randomized, double-blind, controlled study. Curr Ther Res Clin Exp. 2013 Dec;75:64-70. doi: 10.1016/j.curtheres.2013.09.003.
Related trials for Elective Caesarean Section Surgeries
Not yet recruiting
Esketamine Combined With Transcutaneous Electrical Acupoint Stimulation on Postoperative Recovery Quality After Elective Cesarean Section
Cesarean Section (MeSH: D002585), Postoperative Pain After Cesarean Section
RecruitingPhase 4
Carbetocin Monotherapy Versus Carbetocin Plus Oxytocin Infusion in Elective Cesarean Delivery: A Non-Inferiority Trial
Postpartum Hemorrhage, Uterine Atony
Enrolling by invitation
A Randomized Controlled Trial Comparing the Incidence of Surgical Site Infections in Cesarean Section With and Without Subcutaneous Drain Placement at Queen Savang Vadhana Memorial Hospital
Surgical Site Infection (SSI)
RecruitingEarly Phase 1
Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Cesarean Delivery, Postpartum Hemorrhage (PPH)
Recruiting
Local Subcutaneous Gentamicin for Prevention of Surgical Site Infection After Elective Cesarean Section
Surgical Site Infection
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anis Aribogan, Prof., MD study director
Baskent University School of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Group Fentanyl, Group sufentanil and Ephedrine in people with Elective Caesarean Section Surgeries, run by Baskent University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 May 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparison of the effect of adding fentanyl or sufentanil to levobupivacaine (2.2±0.2 ml 0.5%) on intraoperative anesthesia quality block characteristics side effects on newborn and mother,duration of postoperative analgesia,surgeon satisfaction score (time frame: during caesarean section and postoperative first 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01858090, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 May 2013.